Lyell Immunopharma, Inc.
LYEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$343 | -$235 | -$183 | -$250 |
| Dep. & Amort. | $20 | $20 | $16 | $14 |
| Deferred Tax | $0 | $0 | $0 | $40 |
| Stock-Based Comp. | $33 | $0 | $0 | $62 |
| Change in WC | -$3 | $3 | -$82 | $4 |
| Other Non-Cash | $131 | $47 | $79 | $5 |
| Operating Cash Flow | -$162 | -$164 | -$170 | -$126 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$3 | -$24 | -$66 |
| Net Acquisitions | -$31 | $0 | $0 | $673 |
| Inv. Purchases | -$395 | -$477 | -$406 | -$673 |
| Inv. Sales/Matur. | $549 | $664 | $419 | $617 |
| Other Inv. Act. | $0 | $0 | $0 | -$673 |
| Investing Cash Flow | $122 | $184 | -$12 | -$122 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $2 | $11 | $392 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | $9 |
| Financing Cash Flow | $1 | $2 | $11 | $401 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$39 | $22 | -$170 | $153 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $146 | $124 | $294 | $141 |
| End Cash | $107 | $146 | $124 | $294 |
| Free Cash Flow | -$163 | -$166 | -$194 | -$192 |